CTRI/2024/07/071054招募中2 期
Evaluation of efficacy and safety of NR-INF-IB on skin in healthyparticipants - A randomized, double-blind, placebo controlled,prospective clinical study - NI
atural Remedies Pvt Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Healthy male and female participants (Healthy individuals will be defined as who do not require any continuous or urgent medical or surgical treatment for any systemic disease. Also with respect to skin, healthy skin will be defined as those without any skin blemishes of infective or non infective pathology like acne, hyper pigmentation or hypopigmentation etc.)
- •2. Willing to provide informed consent and comply with all requirements of the study protocol including follow up visits
排除标准
- •1.Participants with non intact skin surface for instrumental assessment (wounds, moles etc.)
- •2. Pregnant or nursing woman or planning a pregnancy during the study.
- •3. Participants with a skin tattoo, scar(s), mole(s), excessive hairs or any
- •condition of the skin surface, which might interfere with the evaluation.
- •4. Participants who have been exposed to excessive sunlight or UV-rays within the previous month and are anticipated to be exposed during the study period.
- •5. Participants diagnosed with or having a history of hypertension, hyper or hypothyroidism
- •6. Participants diagnosed with anemia or are known cases of diabetes.
- •7. Participants suffering from any severe or progressive systemic or local disease or any other pathology that may interfere with the evaluation of the study results.
- •8. Participants with known history of or suffering from autoimmune disease and/or immune deficiency.
- •9. Participants suffering from inflammatory and/or infectious cutaneous disorders in or near the studied zones (herpes, acne, mycosis, papilloma)
- •10. Participants having received laser treatment or derma abrasion, surgery, deep chemical peeling or other ablative procedure on the cheeks or the neckline area within the past 1 month prior to the study
- •11. Participants having received resorbable filling product (injection) in the cheeks or the neckline area within the past 18 months prior to the study
- •12. Participants undergoing topical treatment on the test area or a systemic treatment including anti-histamines for the past 2 weeks prior to study; immunosuppressive and or corticoids for the last 4 weeks prior to study; retinoid for the 6 months prior to the study.
- •13. Known hypersensitivity to any of the ingredients of test products
- •14. Other conditions, which in the opinion of the investigators, makes the patient unsuitable for enrolment or could interfere with his or her participation in the stud
研究者
相似试验
招募中
2 期
Comparison of intracoronary selected CD 133+ bone marrow stem cells in cardiac recovery after acute myocardial infarct and left ventricular dysfunction: COMPARE-AMI a randomized controlled double blind clinical studyHeart failureACTRN12609001045202Miltenyi Biotech Inc.40
招募中
不适用
Investigation of the safety and effectiveness of irreversible electroporation (IRE) using the NanoKnife® System in patients with unresectable stage 3 pancreatic cancer who have received 3 months of chemotherapy.Cancer - PancreaticPancreatic CancerACTRN12621000955819Walter & Eliza Hall Institute of Medical Research (WEHI)20
尚未招募
2 期
Comparison of safety and efficacy of chemical method vs mechanical method in inducing labour pains in a term pregnant motherCTRI/2020/08/027093Dr Maya menon
撤回
3 期
Evaluation of the Safety and Efficacy of Using Insulin-like Growth Factor-1 in Patients With a Heart Attack (RESUS-AMI)acute myocardial infarction with LVEF< 30%heart attack with heartfailure10011082NL-OMON40846niversity college Cork, Centre for Research in Vascular Biology Bio Sciences Institute15
已完成
不适用
Assessment of efficacy and safety profile of irbesartan/amlodipine single-pill combination drug in uncontrolled-hypertension with type 2 diabetic patients.JPRN-UMIN000010266Kanazawa Medical University Diabetes and Endocrinology50